For those surviving encephalitis, the influence on daily life of patients and their relatives may be substantial. In contrast, the prognosis after aseptic meningitis (ASM) is considered good. In this prospective study in patients with encephalitis (n = 20) and ASM (n = 46), we show that both groups experienced reduced Health Related Quality of Life (HRQoL) at two months after discharge, and that workability was reduced in 37% of the patients with ASM. However, 12 months after discharge no neuropsychological deficits were detected in the ASM group, whereas patients with encephalitis had lower scores on tests of fine motor and psychomotor skills as well as on learning and memory. We also found that for patients with encephalitis, neopterin, as a marker of Th1 cell induced macrophage activation, and a putatively neurotoxic ratio of the kynurenine pathway (KP) measured during the acute phase was associated with lower HRQoL. Our data show that not only encephalitis, but also ASM has substantial short-term influence on HRQoL and workability. For patients with encephalitis we suggest a link between immune activation and activation of the KP during the acute phase with impaired HRQoL.
and increased levels of KP metabolites in the cerebrospinal fluid (CSF) from patients with encephalitis and ASM compared to patients without CNS infection 21 . Moreover, for patients with encephalitis we found that neopterin, as a marker of interferon (IFN)-γ activity, correlated with the rate-limiting step of the KP (i.e. indoleamine 2,3-dioxygenase (IDO)) and with a putative neurotoxic ratio of the KP.
In the present study, we aimed to evaluate workability and HRQoL in patients with acute encephalitis and ASM of various and unknown etiology two months after discharge. Secondly, we accessed long-term neuropsychological outcome at 12 months. We also aimed to investigate whether short-term outcome was related to clinical findings and previously reported, dysregulated neopterin and KP metabolites during the acute phase of the infection.
Methods
Study design and patients. This prospective observational study was performed at Oslo University Hospital, Ullevål between January 2014 and June 2018. During the first two years (2014-2015) all patients presenting with acute symptoms of CNS infection at the Department of Medicine and Neurology who underwent a lumbar puncture (LP) were included (n = 244). Of these, 32 of the 45 patients who fulfilled the case definition of ASM and 12 of the 19 patients who fulfilled the inclusion criteria of encephalitis were included in the follow-up study. During the last inclusion period (March 2016-June 2018) only patients from the Department of Infectious Diseases were eligible for inclusion, of 19 cases with ASM, 14 patients were included, whereas all patients diagnosed with encephalitis in this latter inclusion period fulfilled inclusion criteria for the follow-up study (Fig. 1) . The case definition of encephalitis is, as previously published, based on the same criteria and symptoms as stated in the International Encephalitis Consortium case definition (Table 1) 22, 23 . The case definition of ASM is based on a consortium definition published by Tapiainen et al. (Table 1) 24 . Nine patients with ASM had prior to the lumbar puncture been treated with antibiotics, which could results in false negative CSF culturing. For three of these patients, no causing agent was identified, and a negative polymerase chain reaction (PCR) for common causes of bacterial meningitis was required to fulfill the case definition. None of the patients had a positive blood culture. For all patients in this study, in-house real time polymerase chain reaction (PCR) for detection of herpes simplex virus 1 (HSV1) and 2 (HSV2), varicella zoster virus (VZV) and enterovirus were carried out. Analyses for detection of other microbiological agents in CSF and serum were analyzed if clinically relevant 23 . 
Condition

Case definition
Encephalitis Encephalopathy (altered mental function or change in personality) for >24 hours with no other cause identified and at least two of the following: A follow up appointment was scheduled two months after discharge ( Fig. 1 ). Patients with encephalitis and patients diagnosed with ASM after September 2016 were invited to neuropsychological testing 12 months after infection. Patients with premorbid chronic psychiatric disease, addictive disorders or patients with poor Norwegian language skills were excluded. Two patients in the encephalitis group had recently been tested and were excluded from the neuropsychological testing due to test-retest bias ( Fig. 1 ). patient characteristics and clinical data. Clinical and demographic data were obtained during hospital admittance as described in our previous work ( Table 2) 23 . Etiological agents were classified using the criteria given in the review of Granerod et al. 25 , and neopterin from CSF and serum sampled at admission were known. These measurements were analyzed by liquid chromatographytandem mass spectrometry (LC-MS/MS) as previously described 21, 26 . From previous published data, the calculated ratio (KYN/TRP) of the rate-limiting enzyme of the KP in the CNS, i.e. indolamine 2,3-dioxygenase (IDO) and the putatively neuroprotective (i.e. KYNA) to neurotoxic KP metabolites (i.e. 3-HK + QA) were known 21 .
Short-term follow up.
The clinical follow-up included a structured interview on persisting complains and workability (Table 3) , the Glasgow Outcome Scale extended (GOSE) 27 , the Hospital Anxiety and Depression Scale (HAD) 28 and the Survey Short Form (SF-36) 29 . The eight scales of the SF-36 were aggregated in two summary component scores, the Physical (PCS) and Mental (MCS) Component Summary scores 30 . neuropsychological testing and long-term follow up. A wide range of neuropsychological tests was used to measure cognitive function 12 months after discharge from hospital. The chosen neuropsychological test battery was similar to that used in a follow-up study on patients with neuroborreliosis 31 , and was designed to evaluate a broad range of cognitive abilities (Table 4) 32-39 . ethical considerations. All patients gave a written informed consent. The study was approved by The Regional Committees for Medical and Health Research Ethics (REC South East, reference number 2011/2578) and the hospital ethical council, and was conducted according to relevant guidelines and regulations.
Encephalitis (n = 20)
Aseptic meningitis (n = 46) p-value 40, 41 . For PCS and MCS a population mean of 50 was used. To compare results of neurocognitive tests with expected mean, z-scores were calculated. A z-score below −1 SD was considered a deficit. Associations between HRQoL and measurements of immune activation and KP metabolites at admittance were performed with Spearman's rank correlation. Due to the limited sample size, we restricted our correlation analysis with SF-36 measures to previously identified dysregulated KP pathway measures (i.e. neopterin, IDO and KYNA/(3-HK + QA)) to minimize the influence of multiple testing 30 . To limit type II statistical errors, no correction for multiple comparisons was made in this explorative study 42 . All data analyses were performed in SPSS version 24 (IBM Corp. Armonk, NY, USA) and graphs generated by Graphad Prism 8 (GraphPad, San Diego, USA). Long-term outcome and neurocognitive function. The education level was not different between the groups, but the education level was high, 15.5 ± 3 yrs. Moreover, tested encephalitis patients were older (53.5 ± 16.5 vs 37.2 ± 9.7, p = 0.007) and more often men (8/11 (72%) vs 3/13 (23%), p = 0.014). The neuropsychological tests were poorer in the encephalitis group regarding fine motor and psychomotor skills, as well as learning and memory ( Table 4 ). The total number of patients with z-scores below −1 SD was 14% in the encephalitis group compared to 3% in the ASM group.
Association of short-term outcome with KP metabolites and markers of inflammation in CSF
at admittance. We have previously reported markedly enhanced neopterin and IDO levels and a lower ratio of KYNA/(3-HK + QA), particularly in patients with encephalitis, compared to healthy controls 21 . These parameters in the current sub-population are shown in Fig. 3 . To evaluate whether outcome could be related to level of immune activation or activation of the KP, the summary scores of the SF-36 (i.e. PCS and MCS) were used. In patients with encephalitis there was a strong positive correlation between MCS and the putative neuroprotective/ neurotoxic ratio of KYNA/ (3-HK + QA) (Rho 0.9, p = 0.014) and strong inverse correlation with neopterin, as a marker of Th1 cell activation (Rho −0.9, p = 0.007), and IDO (Rho −0.9, p = 0.014) ( Table 5 ). No correlation was found between number of days admitted, CSF white cell counts (WBC) or CSF protein at hospital admittance and PCS and MCS.
Discussion
We evaluated short-and long-term outcome, workability, HRQoL and neuropsychological functioning in patients with encephalitis and ASM of various and unknown etiology. Our main findings were 1) encephalitis and ASM patients have low short-term HRQoL scores compared to the normal population and displayed reduced workability, with more pronounced reductions in encephalitis, 2) in encephalitis, HRQoL as reflected by MCS, correlated with a putative neurotoxic imbalance of the KP, and 3) encephalitis displayed more long-term neurocognitive deficits. Persisting complaints after surviving encephalitis are well known, especially for HSV1-encephalitis 3, 4 . Less is known on outcome and neurocognitive functioning in patients with encephalitis with non-HSV or unknown etiology and ASM. Although comparison with other studies is hampered by different test batteries and time to follow-up, our data support previous findings of reduced HRQoL for patients with ASM, at least on the short-term 8 . However, after 12 months the number of neurocognitive tests with a z-score below −1 SD in the www.nature.com/scientificreports www.nature.com/scientificreports/ ASM group were low (3%), indicating good recovery with no/minimal neurocognitive sequelae. For patients with encephalitis, although no deficits were found in some individuals, the higher numbers (14%) of neuropsychological tests with a z-score below −1 SD indicate more neurocognitive deficits in this group. A major finding in this study was that for patients with encephalitis, MCS (as a marker of HRQoL) was inversely correlated with neopterin levels. IFN-γ is an activator of IDO, the first step of the KP, and neopterin is thought to be a stable and reliable marker of IFN-γ activity 43, 44 . The CSF level of IFN-γ at time of diagnosis has been associated with worse outcome at 3 months in patients with HSV1-encephalitis 13 . During inflammation, activation of the KP results in the formation of metabolites with potential neurotoxic (e.g. QA and 3-HK) and neuroprotective (e.g. KYNA) effects 45 . For the putatively neuroprotective/neurotoxic ratio of the KP (i.e. KYNA/(3-HK + QA)), a positive association was found. Others have found that worse outcome is associated with low KYNA levels during the acute phase, while elevated levels of KYNA has been detected more than one year after onset of HSV1 encephalitis 15 . KYNA is an antagonist of the NMDA receptor, and may antagonize the neurotoxic effect exerted by the QA. However, activation of the KP and elevated levels of KYNA have also been associated with cognitive impairment and psychotic symptoms, possibly through antagonism of the alpha-7 nicotinic acetylcholine receptor (α7nAchR) 46 . Our findings suggest that an imbalance of the KP in the direction of neurotoxic metabolites during www.nature.com/scientificreports www.nature.com/scientificreports/ the acute-phase may be associated with worsened HRQoL for patients with encephalitis. This influence may, at least partly be mediated by increased IFN−γ activity reflecting increased Th1 cellular immune activity with neopterin as a reliable marker.
The strength of this study is the prospective character and the reported findings of reduced HRQoL and persisting complains for as long as two months after discharge. Especially for patients with ASM these findings are of clinical relevance. Moreover, the proportion of identified cause in patients with ASM is high (74%), and shows, as suggested by others, that extensive utilization of PCR in all patients with ASM may increase the number of patients with identified cause 47 . The study has some limitations. The relatively high proportion of patients lost to follow-up (26% and 28% in the encephalitis and the ASM group, respectively) may have biased the results. In the encephalitis group, three patients died as a consequence of their encephalitis, and for three patients comorbidity such as cancer and psychiatric disease led to exclusion from the follow-up study. Moreover, patients that were lost to follow up in the ASM group (Fig. 1) may have represented the healthiest of those diagnosed with ASM. However, except from a higher proportion of detected agents in the encephalitis group not included in the follow-up study, there were no significant differences in clinical and epidemiological characteristics between included and not included patients. Furthermore, pathogenesis and outcome of CNS infections has been shown to depend on the causing agent 48 . However, because of heterogeneous etiology and the small study groups, no sub-analyses could be done, and the statistical power of the analyses is low. We suggest that the reduced HRQoL and neurocognitive functioning in the encephalitis group is caused by the parenchymal character of the infection, including KP activation, but older age and male dominance in the encephalitis group might cause a bias. Likewise, the influence of CNS infection on HRQoL may be overestimated, especially for the ASM group, which consisted of many females in their thirties with a busy family life. Lastly, correlation does not mean causality and given the limited sample size and the explorative nature of the study, there is a need for larger studies to evaluate these issues.
In conclusion, encephalitis, but also ASM have substantial short-term influence on HRQoL and workability. However, according to this study, the long-term prognosis for ASM patients seems good. Our study suggests a link between impaired HRQoL and metabolites of the KP in patients with encephalitis that might represent a novel target for therapy. This should be further evaluated in larger encephalitis cohorts with CSF analyses during follow-up. and ASM (n = 10) measured at admission in comparison with a previously reported control group consisting of patients with no pleocytosis in the CSF 21 . Data shown are medians with IQR. Asterisks above patients groups indicate significant difference vs controls (Mann Whitney U test); **p < 0.01, ***p < 0.001. a KYN/ TRP ratio as a measure of IDO activity. KYN: kynurenine, TRP: tryptophan, KYNA: kynurenic acid, 3-HK: 3-hydroxykynurenine, QA: quinolinic acid.
Encephalitis (n = 7)
Aseptic meningitis (n = 10)
PCS
MCS PCS MCS
KYNA/(3-HK + QA) −0.4 (p = 0.9) 0.9 (p = 0.014) 0.1 (p = 0.7) −0.5 (p = 0.1) Neopterin 0.07 (p = 0.9) −0.9 (p = 0.007) −0.2 (p = 0.7) 0.09 (p = 0.8) IDO 0.143 (p = 0.8) −0.9 (p = 0.014) −0.2 (p = 0.8) 0.006 (p = 0.9) Table 5 . 
